Literature DB >> 26146950

Do neuropsychological test norms from African Americans in the United States generalize to a Zambian population?

Knut A Hestad1, J Anitha Menon2, Robert Serpell2, Lisa Kalungwana2, Sidney O C Mwaba2, Norma Kabuba2, Donald R Franklin3, Anya Umlauf3, Scott Letendre3, Robert K Heaton3.   

Abstract

Healthy Zambian adults (N = 324) were evaluated to determine to what degree a Western neuropsychological (NP) test battery, with African American norms adjusted for age, gender, and education could be used in healthy Zambians, including 157 men (48.46%) and 167 women (51.54%) with an average age of 38.48 (SD = 12.80) years and an average education level of 11.02 (SD = 2.58) years. The NP battery included tests of attention/working memory, executive function, verbal fluency, processing speed, verbal and visual episodic memory, and fine motor skills. The Zambian Achievement Test (ZAT) and the U.S. Wide Range Achievement Test-4 (WRAT-4) reading subtest also were administered to assess literacy and quality of education. Similar to findings in Western countries, the Zambian results show substantial age and education effects on most tests and smaller, less consistent effects of gender. Beyond the basic demographic effects, urban/rural background had small effects on some cognitive variables, and the ZAT (but not WRAT-4) reading level was a robust predictor of performance on many NP tests, even when other background characteristics were controlled. Women in the United States tend to outperform men on tests of processing speed and episodic memory. However, Zambian women showed modest but statistically significant disadvantages versus their male counterparts. The results show that tests developed in the United States may be used in Zambia. Nevertheless, development and use of local cultural norms remains very important and is a must. New demographically corrected norms were developed for the cohort that was examined. (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2015        PMID: 26146950      PMCID: PMC4703578          DOI: 10.1037/pas0000147

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  28 in total

1.  Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment.

Authors:  M J Taylor; R K Heaton
Journal:  J Int Neuropsychol Soc       Date:  2001-11       Impact factor: 2.892

2.  Reading level attenuates differences in neuropsychological test performance between African American and White elders.

Authors:  Jennifer J Manly; Diane M Jacobs; Pegah Touradji; Scott A Small; Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

3.  Initial validation of a screening battery for the detection of HIV-associated cognitive impairment.

Authors:  Catherine L Carey; Steven Paul Woods; Julie D Rippeth; Raul Gonzalez; David J Moore; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  Clin Neuropsychol       Date:  2004-05       Impact factor: 3.535

4.  Neuropsychological test performance among Caribbean-born and U.S.-born African American elderly: the role of age, education and reading level.

Authors:  Desiree A Byrd; Danurys Sanchez; Jennifer J Manly
Journal:  J Clin Exp Neuropsychol       Date:  2005-11       Impact factor: 2.475

Review 5.  Advantages and disadvantages of separate norms for African Americans.

Authors:  Jennifer J Manly
Journal:  Clin Neuropsychol       Date:  2005-06       Impact factor: 3.535

6.  A brief report on WAIS-R normative data collection in Mayo's Older African Americans Normative Studies.

Authors:  John A Lucas; Robert J Ivnik; Glenn E Smith; Tanis J Ferman; Floyd B Willis; Ronald C Petersen; Neill R Graff-Radford
Journal:  Clin Neuropsychol       Date:  2005-06       Impact factor: 3.535

7.  Norwegian norms and factor-structure of phonemic and semantic word list generation.

Authors:  Jens Egeland; Nils Inge Landrø; Evelin Tjemsland; Kjersti Walbaekken
Journal:  Clin Neuropsychol       Date:  2006-12       Impact factor: 3.535

8.  Discrepancies between self-reported years of education and estimated reading level among elderly community-dwelling African-Americans: Analysis of the MOAANS data.

Authors:  Sid E O'Bryant; John A Lucas; Floyd B Willis; Glenn E Smith; Neill R Graff-Radford; Robert J Ivnik
Journal:  Arch Clin Neuropsychol       Date:  2007-03-02       Impact factor: 2.813

9.  Neuropsychological impairment in racial/ethnic minorities with HIV infection and low literacy levels: effects of education and reading level in participant characterization.

Authors:  Elizabeth L Ryan; Reon Baird; Monica Rivera Mindt; Desiree Byrd; Jennifer Monzones; Susan Morgello Bank
Journal:  J Int Neuropsychol Soc       Date:  2005-11       Impact factor: 2.892

10.  Qualitative aspects of verbal fluency in HIV-associated dementia: a deficit in rule-guided lexical-semantic search processes?

Authors:  Steven Paul Woods; Emily Conover; Julie D Rippeth; Catherine L Carey; Raul Gonzalez; Thomas D Marcotte; Robert K Heaton; Igor Grant
Journal:  Neuropsychologia       Date:  2004       Impact factor: 3.139

View more
  11 in total

1.  Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis.

Authors:  Knut A Hestad; Jonathan Chinyama; Menon J Anitha; Mary S Ngoma; J Allen McCutchan; Donald R Franklin; Robert K Heaton
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

2.  Home-versus acquired-language test performance on the Hopkins Verbal Learning Test-Revised among multilingual South Africans.

Authors:  Travis M Scott; Hetta Gouse; John Joska; Kevin G F Thomas; Michelle Henry; Anna Dreyer; Reuben N Robbins
Journal:  Appl Neuropsychol Adult       Date:  2018-09-28       Impact factor: 2.248

Review 3.  Neuropsychological Assessment: Past and Future.

Authors:  Kaitlin B Casaletto; Robert K Heaton
Journal:  J Int Neuropsychol Soc       Date:  2017-10       Impact factor: 2.892

4.  Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: A systematic review.

Authors:  Primrose Nyamayaro; Dixon Chibanda; Reuben N Robbins; James Hakim; Hetta Gouse
Journal:  Clin Neuropsychol       Date:  2019-05-01       Impact factor: 3.535

5.  Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Stian Lydersen; Robert K Heaton; Knut A Hestad
Journal:  Neuropsychology       Date:  2018-03-05       Impact factor: 3.295

6.  Generalizability of demographically corrected Zambian neuropsychological norms to South African women.

Authors:  Christy A Denckla; Georgina Spies; Robert Heaton; Jennifer Vasterling; Donald Franklin; Kristina J Korte; Courtney Colgan; David C Henderson; Karestan C Koenen; Soraya Seedat
Journal:  Clin Neuropsychol       Date:  2019-04-05       Impact factor: 3.535

7.  UDSNB 3.0 Neuropsychological Test Norms in Older Adults from a Diverse Community: Results from the Einstein Aging Study (EAS).

Authors:  Cuiling Wang; Mindy J Katz; Katherine H Chang; Jiyue Qin; Richard B Lipton; Jessica L Zwerling; Martin J Sliwinski; Carol A Derby; Laura A Rabin
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  Clinical Neuropsychological Evaluation in Older Adults With Major Depressive Disorder.

Authors:  Shawn M McClintock; Lex Minto; David A Denney; K Chase Bailey; C Munro Cullum; Vonetta M Dotson
Journal:  Curr Psychiatry Rep       Date:  2021-07-13       Impact factor: 8.081

Review 9.  Neurocognitive Changes in Spinocerebellar Ataxia Type 3: A Systematic Review with a Narrative Design.

Authors:  Kah Hui Yap; Roy P C Kessels; Shahrul Azmin; Bart van de Warrenburg; Norlinah Mohamed Ibrahim
Journal:  Cerebellum       Date:  2021-07-07       Impact factor: 3.648

10.  HIV- and AIDS-associated neurocognitive functioning in Zambia - a perspective based on differences between the genders.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Robert K Heaton; Knut A Hestad
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-11       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.